[HTML][HTML] Small molecule metabolites: discovery of biomarkers and therapeutic targets

S Qiu, Y Cai, H Yao, C Lin, Y Xie, S Tang… - Signal Transduction and …, 2023 - nature.com
Metabolic abnormalities lead to the dysfunction of metabolic pathways and metabolite
accumulation or deficiency which is well-recognized hallmarks of diseases. Metabolite …

[HTML][HTML] Multi-omics profiling for health

M Babu, M Snyder - Molecular & Cellular Proteomics, 2023 - ASBMB
The world has witnessed a steady rise in both non-infectious and infectious chronic
diseases, prompting a cross-disciplinary approach to understand and treating disease …

[HTML][HTML] Mitochondrial dysfunction and therapeutic perspectives in cardiovascular diseases

Y Liu, Y Huang, C Xu, P An, Y Luo, L Jiao… - International journal of …, 2022 - mdpi.com
High mortality rates due to cardiovascular diseases (CVDs) have attracted worldwide
attention. It has been reported that mitochondrial dysfunction is one of the most important …

[HTML][HTML] Calcium overload and mitochondrial metabolism

LL Walkon, JO Strubbe-Rivera, JN Bazil - Biomolecules, 2022 - mdpi.com
Mitochondria calcium is a double-edged sword. While low levels of calcium are essential to
maintain optimal rates of ATP production, extreme levels of calcium overcoming the …

[HTML][HTML] Mitochondria as intracellular signalling organelles. An update

LD Popov - Cellular Signalling, 2023 - Elsevier
Traditionally, mitochondria are known as" the powerhouse of the cell," responsible for
energy (ATP) generation (by the electron transport chain, oxidative phosphorylation, the …

Mitochondrial cristae morphology reflecting metabolism, superoxide formation, redox homeostasis, and pathology

P Ježek, M Jabůrek, B Holendová… - Antioxidants & Redox …, 2023 - liebertpub.com
Significance: Mitochondrial (mt) reticulum network in the cell possesses amazing
ultramorphology of parallel lamellar cristae, formed by the invaginated inner mitochondrial …

Mitochondrial dysfunction in human hypertrophic cardiomyopathy is linked to cardiomyocyte architecture disruption and corrected by improving NADH-driven …

EE Nollet, I Duursma, A Rozenbaum… - European heart …, 2023 - academic.oup.com
Aims Genetic hypertrophic cardiomyopathy (HCM) is caused by mutations in sarcomere
protein-encoding genes (ie genotype-positive HCM). In an increasing number of patients …

Defects in the proteome and metabolome in human hypertrophic cardiomyopathy

MJ Previs, TS O'Leary, MP Morley… - Circulation: Heart …, 2022 - Am Heart Assoc
Background: Defects in energetics are thought to be central to the pathophysiology of
hypertrophic cardiomyopathy (HCM); yet, the determinants of ATP availability are not known …

Phenotypic screening with deep learning identifies HDAC6 inhibitors as cardioprotective in a BAG3 mouse model of dilated cardiomyopathy

J Yang, F Grafton, S Ranjbarvaziri, A Budan… - Science translational …, 2022 - science.org
Dilated cardiomyopathy (DCM) is characterized by reduced cardiac output, as well as
thinning and enlargement of left ventricular chambers. These characteristics eventually lead …

[HTML][HTML] Semaglutide ameliorates cardiac remodeling in male mice by optimizing energy substrate utilization through the Creb5/NR4a1 axis

YL Ma, CY Kong, Z Guo, MY Wang, P Wang… - Nature …, 2024 - nature.com
Semaglutide, a glucagon-like peptide-1 receptor agonist, is clinically used as a glucose-
lowering and weight loss medication due to its effects on energy metabolism. In heart failure …